Inhibition of Thrombin as a Novel Strategy in the Treatment of Scleroderma-Associated Interstitial Lung Disease

QR Code

Inhibition of Thrombin as a Novel Strategy in the Treatment of Scleroderma-Associated Interstitial Lung Disease

None

Saved in:

Bibliographic Details
Main Authors:	Bogatkevich, Galina S., Highland, Kristin B., Akter, Tanjina, Nietert, Paul J., Atanelishvili, Ilia, Ryn, Joanne van, Silver, Richard M.
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/27222
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Interstitial lung disease in systemic sclerosis (systemic scleroderma)
by: L. P. Ananyeva, et al.
Published: (2021-03-01)

Diagnosis and treatment of interstitial lung disease in scleroderma systematica
by: L. P. Ananyeva
Published: (2018-06-01)

RITUXIMAB TREATMENT FOR INTERSTITIAL LUNG INJURY IN SCLERODERMA SYSTEMATICA
by: Lidia Petrovna Ananieva, et al.
Published: (2013-12-01)

Assessment of lung ultrasound in patients with scleroderma systematica and interstitial lung disease
by: Olga Borisovna Ovsyannikova, et al.
Published: (2013-06-01)

SCLERODERMA SYSTEMATICA WITH INTERSTITIAL LUNG LESION: COMPARATIVE CLINICAL CHARACTERISTICSWITH PATIENTS WITHOUT LUNG LESION
by: Lyudmila Valeryevna Teplova, et al.
Published: (2010-06-01)

Current therapy of interstitial pneumonia associated with systemic scleroderma
by: L. P. Ananieva
Published: (2020-11-01)

IMPORTANCE OF CYCLOPHOSPHANUM IN THE TREATMENT OF INTERSTITIAL LUNG LESION IN PATIENTS WITH SCLERODERMA SYSTEMATICA (A REVIEW OF LITERATURE)
by: Olga Aleksandrova Koneva
Published: (2010-06-01)

The resolution of the Expert Council on Interstitial Lung Diseases in Systemic Scleroderma (Moscow, October 14, 2019)
by: S. N. Avdeev, et al.
Published: (2020-03-01)

CLINICAL EVALUATION OF THE MANIFESTATIONS OF INTERSTITIAL LUNG INJURYIN SYSTEMIC SCLERODERMA FROM HIGH-RESOLUTION COMPUTER T OMOGRAPHY DATA
by: L P Anan'eva, et al.
Published: (2011-04-01)

Fibrocytes in Scleroderma Lung Fibrosis
by: Reilkoff, Ronald, et al.
Published: (2012)

Prevalence and risk factors of interstitial lung disease in early systemic sclerosis and systemic sclerosis sine scleroderma: a cross-sectional study
by: Maria Carolina Torres Villarreal, et al.
Published: (2025-01-01)

Interstitial lung diseases and autoimmunity
by: E. L. Nasonov, et al.
Published: (2025-05-01)

Korean Guidelines for the Diagnosis and Management of Interstitial Lung Disease: Other Forms of Interstitial Lung Disease
by: Hyung Koo Kang, et al.
Published: (2025-07-01)

Interstitial lung involvement in rheumatoid arthritis
by: David Vladimirovich Bestaev, et al.
Published: (2014-12-01)

Rheumatoid Arthritis Interstitial Lung Disease
by: Vinik, Ophir, et al.
Published: (2011)

INTERSTITIAL LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS
by: David Vladimirovich Bestaev, et al.
Published: (2012-12-01)

Inhibition of Matrix Metalloproteinase-7 Attenuates Subpleural Fibrosis in Rheumatoid Arthritis-Associated Interstitial Lung Disease
by: Li Xiong, et al.
Published: (2025-06-01)

UNILATERAL LUNG INJURY IN SCLERODERMA SYSTEMATICA: A CASE REPORT
by: R. T. Alekperov, et al.
Published: (2014-09-01)

Lungs intersticial damage and its diagnosis in scleroderma (systemic sclerosis)
by: L V Teplova, et al.
Published: (2008-12-01)

INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS
by: L. P. Ananyeva
Published: (2017-03-01)

Interstitial lung diseases: a view on the problem
by: O. G. Sych, et al.
Published: (2025-06-01)

Pregnancy and Scleroderma
by: Gorgiard, Charlotte, et al.
Published: (2012)

ULTRASOUND SCANNING: POSSIBILITIES AND PROSPECTS OF EVALUATING LUNG INVOLVEMENT IN SYSTEMIC SCLERODERMA
by: Olga Borisovna Ovsyannikova, et al.
Published: (2012-12-01)

Interstitial Lung Disease Associated with Clinically Amyopathic Dermatomyositis
by: Takada, Toshinori, et al.
Published: (2011)

Chronic Fibrosing Interstitial Lung Disease with Progressive Phenotype
by: L. P. Ananieva, et al.
Published: (2021-01-01)

Telomere Shortening in Interstitial Lung Disease: Challenges and Promises
by: Haonan Jin, et al.
Published: (2025-07-01)

Anti-Thrombotic Activity of 3-Deoxysappanchalcone via Inhibiting Platelet Aggregation and Thrombin (FIIa)/Activated Factor X (FXa) Activity
by: Gyuri Han, et al.
Published: (2025-06-01)

Late Diagnosis of Systemic Scleroderma with Vascular Events: Clinical Case
by: Julia S. Bogomolova, et al.
Published: (2024-12-01)

Treatment for systemic scleroderma
by: Rezvaya Tairovich Alekperov, et al.
Published: (2011-09-01)

Scleroderma and Breast Cancer
by: Michalinos, Adamantios, et al.
Published: (2011)

Scleroderma Renal Crisis
by: Chabtini, Lola, et al.
Published: (2012)

Expression of Procoagulant Microparticles Assessed by Thrombin Generation Test in Cirrhosis
by: Mejda Belakremi MD, et al.
Published: (2025-07-01)

Downregulation of LINC00638 contributes to the pathogenesis of rheumatoid arthritis-associated interstitial lung disease via inhibiting the Nrf2/ARE signaling pathway
by: Zhuojun LIAO, et al.
Published: (2025-06-01)

Interstitial lung disease in a female patient with rheumatoid arthritis
by: Yuliya Valeryavna Averkieva, et al.
Published: (2014-03-01)

Use of ultrasound to evaluation interstitial lung disease in rheumatic disease
by: O. B. Ovsyannikova, et al.
Published: (2024-11-01)

Interstitial lung disease as an extra-articular manifestation of rheumatoid arthritis
by: David Vladimirovich Bestaev, et al.
Published: (2013-06-01)

Factors associated with interstitial lung disease in patients with rheumatoid arthritis
by: Benyapa Suppa-Udom, et al.
Published: (2024-09-01)

Korean Guidelines for the Diagnosis and Management of Interstitial Lung Diseases: Sarcoidosis
by: Eun Joo Lee, et al.
Published: (2025-07-01)

Quantitative CT Analysis of Lung Features in Patients with Polymyositis/Dermatomyositis without Interstitial Lung Disease
by: He HEI, et al.
Published: (2025-07-01)

Scleroderma-panniculitis: view of the rheumatologist
by: A. S. Potapova, et al.
Published: (2021-04-01)